HomeCompareNOBL vs PODD

NOBL vs PODD: Dividend Comparison 2026

NOBL yields 2.17% · PODD yields 0.96%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOBL wins by $1.8K in total portfolio value
10 years
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →
PODD
PODD
● Live price
0.96%
Share price
$208.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.34
Full PODD calculator →

Portfolio growth — NOBL vs PODD

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNOBLPODD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NOBL + PODD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NOBL pays
PODD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
PODD
Annual income on $10K today (after 15% tax)
$81.73/yr
After 10yr DRIP, annual income (after tax)
$86.99/yr
At 15% tax rate, NOBL beats the other by $125.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NOBL + PODD for your $10,000?

NOBL: 50%PODD: 50%
100% PODD50/50100% NOBL
Portfolio after 10yr
$22.0K
Annual income
$176.06/yr
Blended yield
0.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PODD right now

NOBL
No analyst data
PODD
Analyst Ratings
36
Buy
10
Hold
3
Sell
Consensus: Buy
Price Target
$357.25
+71.7% upside vs current
Range: $286.00 — $435.00
Altman Z
7.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NOBL buys
0
PODD buys
0
No recent congressional trades found for NOBL or PODD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNOBLPODD
Forward yield2.17%0.96%
Annual dividend / share$2.27$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.9K$21.0K
Annual income after 10y$249.78$102.34
Total dividends collected$2.3K$995.00
Payment frequencyquarterlyquarterly
SectorETFStock

Year-by-year: NOBL vs PODD ($10,000, DRIP)

YearNOBL PortfolioNOBL Income/yrPODD PortfolioPODD Income/yrGap
1← crossover$10,917$217.08$10,796$96.15+$121.00NOBL
2$11,903$221.48$11,649$97.01+$254.00NOBL
3$12,962$225.68$12,562$97.83+$400.00NOBL
4$14,099$229.68$13,540$98.60+$559.00NOBL
5$15,319$233.49$14,587$99.32+$732.00NOBL
6$16,628$237.10$15,708$100.00+$920.00NOBL
7$18,033$240.53$16,909$100.64+$1.1KNOBL
8$19,539$243.78$18,193$101.24+$1.3KNOBL
9$21,154$246.86$19,569$101.81+$1.6KNOBL
10$22,884$249.78$21,041$102.34+$1.8KNOBL

NOBL vs PODD: Complete Analysis 2026

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

PODDStock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Full PODD Calculator →
📬

Get this NOBL vs PODD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NOBL vs SCHDNOBL vs JEPINOBL vs ONOBL vs KONOBL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.